...rights to marketed injectable anticoagulants Fraxiparine nadroparin, a low molecular weight heparin , and Arixtra fondaparinux...

...partially effective against low molecular weight heparin (LMWH) therapies and not effective against the generic fondaparinux...
...$6.5 billion in global sales last year. 2,3 In contrast, global sales of UFH and fondaparinux...
...well under $1 billion. "The strength of protamine's binding interaction is not sufficient to neutralize fondaparinux...

...and biocompatibility assays, the lead reversal agent showed greater neutralization activity against the generic anticoagulant fondaparinux...

...rights to Arixtra fondaparinux and the authorized generic of Arixtra from Aspen. Mylan already sells Arixtra...
...interim distribution deal with Aspen, while Apotex Inc. (Toronto, Ontario) sells the authorized generic of Arixtra...
...sold the rights due to an absence of sales representatives in the U.S. Aspen acquired Arixtra...

...Lee's and ScinoPharm partnered to develop, produce and commercialize fondaparinux, travoprost and bimatoprost in China. Fondaparinux...
...rights to commercialize the products in China. Under the deal, ScinoPharm will provide API for fondaparinux...
...NYSE:AGN, Irvine, Calif.) markets bimatoprost as Lumigan to treat open-angle glaucoma and ocular hypertension. Fondaparinux...

...Phase II Block coagulation Factor Xa Alchemia Ltd. (ASX:ACL); Dr. Reddy's Laboratories Ltd. (NYSE:RDY) Fondared fondaparinux...
...Marketed VTE Registration Atrial fibrillation (AF); stroke; DVT; PE; VTE GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Arixtra fondaparinux...

...syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI) who were initially treated with subcutaneous fondaparinux...

...GlaxoSmithKline said it agreed to sell its injectable anticoagulants Fraxiparine nadroparin and Arixtra fondaparinux and the...
...products from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France). Fraxiparine is low molecular weight heparin , and Arixtra...

...syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI) who were initially treated with subcutaneous fondaparinux...

...branded and generic drug supplier Aspen offered to acquire injectable anticoagulants Fraxiparine nadroparin and Arixtra fondaparinux...
...products from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France). Fraxiparine is low molecular weight heparin , and Arixtra...
...GSK reported £113 million ($171.9 million) in Fraxiparine sales and £94 million ($143 million) in Arixtra...